1. Home
  2. XRAY vs MLYS Comparison

XRAY vs MLYS Comparison

Compare XRAY & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$9.73

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$26.12

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRAY
MLYS
Founded
1899
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2008
2023

Fundamental Metrics

Financial Performance
Metric
XRAY
MLYS
Price
$9.73
$26.12
Analyst Decision
Hold
Strong Buy
Analyst Count
14
7
Target Price
$14.58
$48.67
AVG Volume (30 Days)
4.7M
880.6K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
5.58%
N/A
EPS Growth
33.04
37.43
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$12.59
52 Week High
$17.09
$47.65

Technical Indicators

Market Signals
Indicator
XRAY
MLYS
Relative Strength Index (RSI) 24.31 40.36
Support Level N/A $25.16
Resistance Level $13.06 $31.12
Average True Range (ATR) 0.48 1.58
MACD -0.16 -0.36
Stochastic Oscillator 12.55 6.90

Price Performance

Historical Comparison
XRAY
MLYS

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

Share on Social Networks: